 |
Moderna has awarded its global corporate PR duties to DXTRA Health, a collective of more than 1,500 staffers housed within Interpublic shops.
A cross-disciplined group from Weber Shandwick, Golin and Jack Health will work to bolster the corporate reputation of the COVID-19 vaccine maker and spotlight its research savvy.
DXTRA Health “will further educate the world about Moderna’s mRNA technology and its promise to transform the future of human health,” said Kate Cronin, the company’s chief brand officer.
She told O’Dwyer’s that Moderna was not working with IPG prior to the June 13 DXTRA Health announcement.
“We used FTI for corporate global media relations and Ruder Finn for disease awareness work,” said Cronin, who headed Ogilvy Health before joining Moderna a year ago.
Laura Schoen, DXTRA Health’s chief healthcare officer, will lead the team that will support Moderna’s outreach to employees, policymakers, healthcare providers, vaccine recipients and consumers.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
